Member Info for eviking

I got one example from a friend only a week ago. The FDA did not approve an application because of the way usa uses the dates differently.so let's say the approval date was (uk) 13/02/2019.. USA 02/13/2019

Redbus mentioned that the FDA dont always get it right for unknown reasons.

Panic pure panic set in. It's the the only explanation for the sells by the big four companies. The drop of almost 90% was unexpected for sure. And their respective traders would have had to make a rational decision quickly. I believe now in hidsight that it could have been a overreaction.

Thanks ivy make a lot of sense. Good research.

Thanks. Clearly no issue 1500 patients ok. It must hang on motif clarification of minor issues for sure. I do believe motif will provide an update very shortly. Looking to raise cash is one insensitive.

Anyone out there with a "close connection" to the FDA jargon ?

Compute : it could be a submitting error or FDA needs more time. Well this is hilarious a 87%drop on a possible error reporting or more time needed for the FDA. Wait and see approach for me now.

Ian.B and ivyspivey and for that matter everyone else. What I need, to make a decision on the investment long term is this. Do you have any doubts about the toxicity of the liver from Iclaprim.

PrivateRyan. I need to know what your really think is the BOTTLE neck in the FDA decision. We need active thinking?

DPrever explain your posting in layman terms please. Not a science tutor.

Thanks. Please explain in layman term what this means?

FDA ask : we need a detailed report about liver toxicity in your study? Have you got it?
FDA ask : we messed up the application can you please email it again ?

Millions was lost for nothing IMHO. The Fda application is still open for Motif bio. The company is very optimistic about its future for sure. Great science great know how.

The application is still on with the FDA. It only requires motif to supply additional information to get the all clear. Nothing has changed. its a win win for patient as well.

Just shows that the big investors are not logged on. Nothing has changed appart for the share price. The issue is a minor error in the interpretation.

This treatment is paramount for the older generation for sure. Motif has a bright future for the treatment of skin infections all around the world people are living longer and enjoying it.

Anyway the black horse done us proud today what a finish well done.

Wrong board mbb is trading at 77.10 atm. Good luck no posters at all.

Motif has presented all evidence to the FDA. The issue will be resolved in a few months time ok. Just a small setback it happends in a lot of cases getting final approval. Watch this space. Do you really think that all the hard work motif has done researching for years would lost because of a small setback? Nonsense for sure...

Don't think so marineville guess people get stunned by big losses.